Yahoo India Web Search

Search results

    • Clinician-scientist

      • Dr. Srivastava is a clinician-scientist who is strongly committed to cross-disciplinary patient-oriented research focused on the discovery and validation of novel non-invasive biomarkers that will identify high-risk patients with kidney diseases to optimize the conduct of clinical trials and serve as tools for drug development.
      uicollaboratory.uic.edu/8229-anand-srivastava
  1. People also ask

  2. Dr. Srivastava is a Chairman and Cofounder of the California-based Global Institute of Stem Cell Therapy and Research (GIOSTAR) headquartered in San Diego, California (USA).

    • Special Stem Issues of Journals Devoted to Dr. Srivastava
    • The Following Summarizes Dr. Srivastava’s Major Scientific Achievements
    • Expert Scientific Reviewer For Leading Journals of Medicine
    • Fellowships/ Awards
    • Dr. Srivastava’s Excellence in Several Advanced Biological Techniques
    Current Topics of Medicinal Chemistryamong top five medicinal chemistry journal devoted its special issue of stem cell to Dr. Srivastava in 2010.
    Stem Cell Internationaldevoted its special issue on stem cells to Dr. Srivastava in 2012.
    Potentials of ES cell therapy in neurodegenerative diseases(Curr Pharm Des; 2008;14:3873-9) by Dr. Srivastava is still holding number one position among top 20 articles published since 2008 in the...
    Srivastava developed the animal material free and serum free Human embryonic Stem cell culture condition to use the Human ES cells to treat the human diseases.
    Srivastava for the first time showed that if the ES cell injected into developing fetuses in utero takes participation in development of all body of a living organism.
    For the first time he showed that ES cell is better accepted by the transplanted animals in comparison to adult stem cells.
    For the first time he showed the way to generate the high number of pre-erythrocytes using glucocorticoid hormone. Which may be use to treat several blood diseases.

    Dr. Srivastava is the member of the several scientific review committees and reviewing the research grants. He has written several review articles and scientific manuscripts. He is also the reviewer of several scientific journals. 1. Advances in Stem Cells 2. Current pharmaceutical Design 3. Current Topics in Medicinal Chemistry 4. Stem Cells 5. St...

    GRANTS AND AWARDS FUNDING RELATED TO DR. ANAND SRIVASTAVA’S WORK 1. Government of India grant to establish Red Blood Cell from Stem cell (2015 to 2017) 2. Canada Grand Challenge grant award, Canada, Development of tuberculosis (TB) test in TB patients, (2013-2014). 3. Government of India grant to establish stem cell transplant center (2009 – till d...

    Techniques related to Human Embryonic Stem Cell Human Embryonic Stem cell culture, Serum free and feeder free hES cell culture, in vitro differentiation of hES cells into neural cells, in vitro differentiation of hES into hematopoietic cells and red blood cells under the control of cytokines. Gene regulation studies using RT-PCR, Real time PCR, Nor...

  3. www.linkedin.com › company › giostar-indiaGIOSTAR INDIA - LinkedIn

    - The Chairman and Co-founder of GIOSTAR – Dr. Anand Srivastava has been credited as the pioneer, who is responsible for starting the field of modern stem cell science 20 years ago at the...

  4. View Anand Srivastava, MS, PhD’s profile on LinkedIn, a professional community of 1 billion members. Dr. Anand Srivastava is the world-renowned authority and one of the pioneers...

    • 500+
    • San Diego Metropolitan Area
    • 3.4K
  5. Dr. Srivastava is the Chairman and Cofounder of world largest and pioneering research institute, Global Institute of Stem Cell Therapy and Research (GIOSTAR) headquartered in San Diego, California, (U.S.A.).

  6. Dr. Anand Srivastava is the Chairman, Co-Founder, and Chief Scientific Officer of GIOSTAR. He has been involved in numerous studies, publications, and other activities to advance the field of regenerative medicine, and aid in the development of therapeutic approaches to the world's most devastating diseases.

  7. May 3, 2021 · The Society of American Asian Scientists in Cancer Research (SAASCR) honored GIOSTAR Chairman and Co-Founder Dr. Anand Srivastava with their prestigious Outstanding Achievement Award for 2020. Dr. Srivastava was one of only 10 scientists to receive this accolade, presented at SAASCR’s Annual Meeting on April 11, 2021.